Asia Pacific Pharmaceutical Contract Manufacturing And Research Services Market
Asia Pacific Pharmaceutical Contract Manufacturing And Research Services Market, 2018-2030 (US$M)
Global Market
Related Markets
Asia Pacific pharmaceutical contract manufacturing and research services market highlights
- The Asia Pacific pharmaceutical contract manufacturing and research services market generated a revenue of USD 101,896.5 million in 2023.
- The market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
- In terms of segment, manufacturing was the largest revenue generating service in 2023.
- Research is the most lucrative service segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 101,896.5 million |
| Market revenue in 2030 | USD 173,901.2 million |
| Growth rate | 7.9% (CAGR from 2023 to 2030) |
| Largest segment | Manufacturing |
| Fastest growing segment | Research |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Manufacturing, Research |
| Key market players worldwide | Catalent Inc, Pharmaceutical Product Development, AbbVie Inc, Baxter International Inc, Grifols SA Ordinary Shares - Class A, Dalton Pharma Services, Boehringer Ingelheim, Lonza Group Ltd |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 41.7% of the global pharmaceutical contract manufacturing and research services market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 173,901.2 million by 2030.
Asia Pacific held the largest market share of 41.3% in 2022 and is expected to maintain this dominance over the forecast period.
This projected growth can be attributed to factors such as improved social insurance schemes as well as constantly improving economic conditions in the region, which allows patients to pay pharmaceutical costs out-of-pocket.
In recent years, countries such as Singapore, China, and India have been observed to be major players in the pharmaceutical industry owing to their expanding manufacturing capabilities.
No credit card required*
Publish Date: Jul 03, 2024
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Pharmaceutical Contract Manufacturing Market
Pharmaceutical Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Baxter International Inc | View profile | 60,000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | www.baxter.com |
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | www.boehringer-ingelheim.com/ |
| Catalent Inc | View profile | 17,219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | www.catalent.com |
| Grifols SA Ordinary Shares - Class A | View profile | 23,737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | www.grifols.com |
| Pharmaceutical Product Development | View profile | 10001+ | Wilmington, North Carolina, United States, North America | ppd.com |
| Dalton Pharma Services | View profile | 51-100 | Toronto, Ontario, Canada, North America | www.dalton.com/ |
Asia Pacific pharmaceutical contract manufacturing market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Pharmaceutical Contract Manufacturing And Research Services Market will help companies and investors design strategic landscapes.
Manufacturing was the largest segment with a revenue share of 66.15% in 2023.
Horizon Databook has segmented the Asia Pacific pharmaceutical contract manufacturing and research services market based on manufacturing, research covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific held the largest market share of 41.3% in 2022 and is expected to maintain this dominance over the forecast period.
This projected growth can be attributed to factors such as improved social insurance schemes as well as constantly improving economic conditions in the region, which allows patients to pay pharmaceutical costs out-of-pocket.
In recent years, countries such as Singapore, China, and India have been observed to be major players in the pharmaceutical industry owing to their expanding manufacturing capabilities.
- Asia Pacific Pharmaceutical Contract Manufacturing And Research Services Market Service Outlook (Revenue, USD Million , 2018-2030)
- Manufacturing
- Research
Reasons to subscribe to pharmaceutical contract manufacturing market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of pharmaceutical contract manufacturing market databook
- Our clientele includes a mix of pharmaceutical contract manufacturing market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific pharmaceutical contract manufacturing market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Asia Pacific Pharmaceutical Contract Manufacturing And Research Services Market, 2018-2030 (US$M)
Asia Pacific pharmaceutical contract manufacturing market statistics, by service, 2018-2030 (US$M)
